Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fox

Showing results (951-960 of 1,012) with videos related to

Pageof 102
Sort By:
Scientific Reports|July 2, 2020
Venom alkaloids against Chagas disease parasite: search for effective therapiesRafael C M Costa Silva, Eduardo G P Fox, Fabio M Gomes, et al.
The Lancet. Global Health|April 18, 2021
Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trialRisa M Hoffman, Crispin Moyo, Kelvin T Balakasi, et al.
Bone Marrow Transplantation|April 25, 2017
High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective studyE Schorb, C P Fox, K Fritsch, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 11, 2010
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study groupMario E Lacouture, Michael L Maitland, Siegfried Segaert, et al.
Blood Advances|August 8, 2020
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP deliveryMatthew R Wilson, Toby A Eyre, Nicolas Martinez-Calle, et al.
Symbiosis (Philadelphia, Pa.)|March 13, 2026
A review of the venom microbiome and its utility in ecology and evolution including future directions for emerging researchMarina E De León, Eduardo G P Fox, Sara Dunaj, et al.
Bone Marrow Transplantation|November 9, 2019
Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemiaMauricette Michallet, Peter Dreger, Mohamad Sobh, et al.
Blood|April 21, 2024
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trialSridhar Chaganti, Shanna Maycock, Graham McIlroy, et al.
British Journal of Haematology|July 6, 2016
NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndromeToby A Eyre, Ruth Clifford, Adrian Bloor, et al.
Epidemiology (Cambridge, Mass.)|June 5, 2018
Stratified Probabilistic Bias Analysis for Body Mass Index-related Exposure Misclassification in Postmenopausal WomenHailey R Banack, Andrew Stokes, Matthew P Fox, et al.
Pageof 102

Showing results (951-960 of 1,012) with videos related to

Sort By:
Pageof 102
Scientific Reports|July 2, 2020
Venom alkaloids against Chagas disease parasite: search for effective therapiesRafael C M Costa Silva, Eduardo G P Fox, Fabio M Gomes, et al.
The Lancet. Global Health|April 18, 2021
Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trialRisa M Hoffman, Crispin Moyo, Kelvin T Balakasi, et al.
Bone Marrow Transplantation|April 25, 2017
High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective studyE Schorb, C P Fox, K Fritsch, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 11, 2010
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study groupMario E Lacouture, Michael L Maitland, Siegfried Segaert, et al.
Blood Advances|August 8, 2020
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP deliveryMatthew R Wilson, Toby A Eyre, Nicolas Martinez-Calle, et al.
Symbiosis (Philadelphia, Pa.)|March 13, 2026
A review of the venom microbiome and its utility in ecology and evolution including future directions for emerging researchMarina E De León, Eduardo G P Fox, Sara Dunaj, et al.
Bone Marrow Transplantation|November 9, 2019
Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemiaMauricette Michallet, Peter Dreger, Mohamad Sobh, et al.
Blood|April 21, 2024
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trialSridhar Chaganti, Shanna Maycock, Graham McIlroy, et al.
British Journal of Haematology|July 6, 2016
NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndromeToby A Eyre, Ruth Clifford, Adrian Bloor, et al.
Epidemiology (Cambridge, Mass.)|June 5, 2018
Stratified Probabilistic Bias Analysis for Body Mass Index-related Exposure Misclassification in Postmenopausal WomenHailey R Banack, Andrew Stokes, Matthew P Fox, et al.
Pageof 102